Stock Market News for July 6, 2026

Deals, financing and big-ticket transactions

S&P Global (MBGL) released pro forma and recast financials with updated segment reporting, clarifying post‑transaction economics and helping refine valuation and market outlook; see the recast results.

Blackstone (BX) Energy Transition Partners agreed to acquire Dresser Utility Solutions from First Reserve, a strategic buy that expands Blackstone’s grid‑infrastructure exposure; read the deal announcement.

Western Alliance Bank (WAL) financed the $33M first phase of the Marble Manor redevelopment in Las Vegas, a project loan that highlights regional CRE activity and the bank’s commercial real‑estate foothold; see the notice.

Tutor Perini (TPC) completed the redemption of $400 million of senior notes and amended its credit facilities, trimming leverage and altering capital structure—investors should watch cash flow and bid readiness; see the filing.

Voyager (VOYG) closed an upsized $250 million credit facility, bolstering liquidity amid volatile crypto markets; read the notice.

Oceaneering (OII) increased its revolving credit facility to $345 million, enhancing liquidity for offshore services and subsea programs—see the update.

Corporate moves, capital markets and debt

Nuvation Bio (NUVB) announced the full exercise of the greenshoe option in its $287.5 million convertible senior notes offering, strengthening near‑term capitalization and supporting R&D funding without immediate dilution; read the announcement.

Cloudastructure (CSAI) removed a variable conversion feature from its convertible debt and provided an update on its Q1 2026 filing, a balance‑sheet simplification that reduces investor conversion uncertainty; see the filing.

Rivian (RIVN) kicked off an underwritten public offering of common stock, a capital‑raising move that could dilute existing holders but fuel production and margin initiatives—companies in the EV space often tap equity to fund scaling; read the notice.

AI, cloud data and cybersecurity

TeraWulf (WULF) announced an Anthropic lease at its Justified Data Campus and sold a majority interest in the Abernathy JV to Fluidstack—an endorsement of AI compute demand that can affect future hosting revenue.

Galaxy (GLXY) completed Phase I of its Helios data center campus, delivering 133 megawatts of critical IT load to CoreWeave. That level of capacity underscores sustained hyperscaler and AI‑inference demand, supporting potential long‑term contracted revenue.

Tech earnings and corporate results to watch

Cadence (CDNS) set a date for its second‑quarter 2026 results webcast. Investors will parse guidance and design‑win commentary for semiconductor software demand and long‑cycle visibility.

Impinj (PI) announced it will report second‑quarter 2026 results, a release that could sway RFID adoption narratives and channel inventory expectations.

Upstart (UPST) said it will report second‑quarter 2026 results on Aug. 4, a date investors should flag to reassess credit performance and loss forecasts for the lending‑tech space.

Flotek (FTK) set its second‑quarter 2026 earnings release and call, a routine oilfield‑services update that can reveal activity and pricing trends for energy services providers.

Biotech, M&A and clinical catalysts

Vertex (CRNX) will acquire Crinetics Pharmaceuticals (CRNX), strengthening Vertex’s pipeline; investors should watch transaction terms and expected R&D synergies—see the announcement.

InMed Pharmaceuticals (INM) and Mentari Therapeutics amended their merger agreement and filed a registration statement on Form S‑4, moving a planned combination closer to a shareholder vote and potential strategic scale‑up; read the statement.

Organogenesis (ORGO) announced FDA acceptance of a Biologics License Application for ReNu® for symptomatic knee osteoarthritis—BLA acceptance starts an FDA review clock and raises commercial upside if approved; read the filing.

Aligos Therapeutics (ALGS) received an upfront of $25M from an exclusive Greater China license for pevifoscorvir sodium in chronic HBV—this non‑dilutive cash infusion de‑risks near‑term funding; details in the release.

Vaxart (VXRT) reported topline 12‑month safety data from the 400‑participant Sentinel cohort in its Phase 2b oral COVID‑19 vaccine trial—clean safety reads preserve program value ahead of efficacy milestones; see the update.

Incyte (INCY) completed its acquisition of Vega Therapeutics, adding hematology assets that could shift R&D priorities; read the deal announcement.

Genmab (GMAB) and AbbVie (ABBV) won European approval for TEPKINLY® (epcoritamab) in combination therapy for relapsed or refractory follicular lymphoma—regulatory expansion supports the franchise’s commercial outlook; see Genmab’s notice and AbbVie’s statement.

Defense, national security and government contracts

Lockheed Martin (LMT) agreed to acquire Ultra Maritime Solutions, expanding maritime and autonomous surface capabilities—this broadens addressable defense programs; read the release.

AeroVironment (AVAV) had its Titan™ selected by JIATF‑401 for an $80.5M award—this lifts backlog and underscores demand for persistent surveillance platforms; see the notice.

Industrial, restructuring and corporate finance

TPI Composites (TPIC) successfully emerged from Chapter 11 under new ownership, restoring operating continuity for blade supply chains and restructuring balance‑sheet risk; read the reorganization notice.

Curtiss‑Wright (CW) announced an $80 million multi‑year investment to expand operations in Cheswick, Pennsylvania—an industrial capex boost that supports long‑term manufacturing capacity and local hiring.

Autos, EVs and mobility

Wallbox (WBX) announced NYSE acceptance of a plan to regain compliance with continued listing standards—investors should watch remediation milestones and potential trading impacts; read the filing.

Rivian (RIVN)'s public offering is the day's most market‑sensitive mobility story—equity issuance can fund capacity and reduce cash burn, but expect share‑price pressure and near‑term volatility for the EV cohort.

Energy, minerals and commodity operations

CNX Resources (CNX) scheduled its second‑quarter 2026 results and Q&A, where investors will focus on production, realized prices and drilling economics.

Equinox Gold (EQX) announced a sale of shares of Versamet Royalties, a monetization move that trims noncore holdings and can free cash for development; see the release.

Grupo Aeroportuario del Pacífico (PAC) reported a 5.1% decrease in passenger traffic in June versus 2025, a datapoint that affects regional travel recovery assumptions and airport revenue trajectories; read the update.

Donner (DBGI) launched legal actions and retained advisors to investigate alleged naked shorting, spoofing and market manipulation—such public legal campaigns can influence share supply narratives and trader attention; see the statement.

Market activity, sentiment and index flows

Schwab (SCHW) said its Schwab Trading Activity Index™ (STAX) hit a four‑year high in June, signaling elevated retail and institutional trading—higher activity often translates to stronger commission and order‑flow revenue; read the index note.

Franklin Resources (BEN) released preliminary month‑end assets under management, an early gauge of flows that can presage quarterly AUM trends and fee‑revenue momentum; see the update.

Context Therapeutics (CNTX) was added to the Russell 2000® and Russell 3000® indexes—index inclusion can drive passive inflows and short‑term volatility; see the announcement.

Corporate moves, governance and listings

Canaan Inc. (CAN) completed its transfer to the Nasdaq Capital Market, a listing change that can affect liquidity and index inclusion considerations; see the filing.

Empery Digital (EMPD) terminated a limited‑duration shareholder rights plan—a governance change that may influence takeover defenses and shareholder activism; read the notice.

Digimarc (DMRC) appointed Paul Carreiro as CEO and President, a leadership change that could reshape product strategy and go‑to‑market execution.

Other operational updates investors should note

• SEALSQ Corp (LAES) reported preliminary H1 2026 results with revenue up ~120% and reaffirmed full‑year 2026 guidance—strong top‑line growth that merits watching for margin progression and cash generation; read the release.
• RxSight (RXST) disclosed preliminary Q2 financials and product pipeline updates and announced a collaboration with Alcon to develop adjustable PCIOLs—an alliance that could broaden commercial channels for ophthalmic implants; see the financial update and collaboration notice.
• Galaxy’s (GLXY) Helios campus Phase I completion (see above) signals continued data‑center build activity supporting AI hosting demand.
• Dorchester Minerals (DMLP) agreed to acquire mineral and royalty interests, modestly expanding its legacy oil & gas portfolio; read the announcement.
• Curbline Properties (CURB) announced record Q2 2026 investment activity, signaling stronger deal flow and deployment—see the release.
• ProShares (SKHU) is expected to launch a 2x single‑name ETF on SK hynix on July 13—leveraged ETFs can amplify flows and volatility in the underlying stock; see the listing notice.
• Flotek (FTK) and other small‑caps scheduling earnings calls this season are worth monitoring for sector signal and guidance changes; see company releases above for dates.

Regulatory rulings and market access

Wrap Technologies (WRAP) received an ATF ruling classifying the BolaWrap® 150 as an instrument of restraint rather than a firearm—this removes a regulatory hurdle and may ease law‑enforcement adoption; read the ruling.